BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8620625)

  • 1. Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infection.
    Jouen-Beades F; Gilbert D; Ramzaoui S; Borsa-Lebas F; Humbert G; Tron F
    Clin Immunol Immunopathol; 1996 May; 79(2):189-93. PubMed ID: 8620625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunopathogenesis of retroviral diseases: no immunophenotypic alterations in T, B, and NK cell subsets in SIVmac239-challenged rhesus macaques protected by SIV delta nef vaccination.
    Giorgi JV; Hultin LE; Desrosiers RC
    J Med Primatol; 1996 Jun; 25(3):186-91. PubMed ID: 8892039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of activated gamma delta lymphocytes correlates with disease severity in HIV infection.
    Norazmi MN; Arifin H; Jamaruddin MA
    Immunol Cell Biol; 1995 Jun; 73(3):245-8. PubMed ID: 7590898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
    Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
    Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection.
    Hyjek EM; Bartkowiak J; Drozdz R; Wasik TJ; Jasinski M; Kaneko Y; Lischner HW; Kozbor D
    J Immunol; 1997 Jan; 158(1):464-74. PubMed ID: 8977224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
    Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
    Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
    Prince HE; Jensen ER
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1227-32. PubMed ID: 1719188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
    AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+CD38+ and CD8+DR+ peripheral blood lymphoid subsets of HIV-infected intravenous drug abusers correlate with CD4+ cell counts and proliferation to mitogens.
    Echaniz P; Arrizabalaga J; Iribarren JA; Cuadrado E
    Cell Immunol; 1993 Aug; 150(1):72-80. PubMed ID: 7688270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.
    Mocroft A; Bofill M; Lipman M; Medina E; Borthwick N; Timms A; Batista L; Winter M; Sabin CA; Johnson M; Lee CA; Phillips A; Janossy G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):158-62. PubMed ID: 9052725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories.
    Reimann KA; Chernoff M; Wilkening CL; Nickerson CE; Landay AL
    Clin Diagn Lab Immunol; 2000 May; 7(3):352-9. PubMed ID: 10799445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets.
    McCloskey TW; Kohn N; Lesser M; Bakshi S; Pahwa S
    Cytometry; 2001 Jun; 46(3):157-65. PubMed ID: 11449406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.